291 related articles for article (PubMed ID: 33251678)
21. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
Zhao L; Wang Y; Liu Q
Exp Mol Pathol; 2019 Aug; 109():51-60. PubMed ID: 31145886
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
23. microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma.
Lu Z; Li X; Xu Y; Chen M; Chen W; Chen T; Tang Q; He Z
Cell Death Dis; 2019 Sep; 10(10):723. PubMed ID: 31558704
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
[TBL] [Abstract][Full Text] [Related]
26. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
Xia W; Ni J; Zhuang J; Qian L; Wang P; Wang J
Int J Biochem Cell Biol; 2016 Feb; 71():1-11. PubMed ID: 26646106
[TBL] [Abstract][Full Text] [Related]
27. microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma.
Song WH; Feng XJ; Gong SJ; Chen JM; Wang SM; Xing DJ; Zhu MH; Zhang SH; Xu AM
Cancer Biol Ther; 2015; 16(12):1754-63. PubMed ID: 26467022
[TBL] [Abstract][Full Text] [Related]
28. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
29. Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR-101-3p/Wee1 axis.
Sun L; Cai H; Zhou T; Xiang H; Long L
Drug Dev Res; 2022 Jun; 83(4):891-899. PubMed ID: 35080031
[TBL] [Abstract][Full Text] [Related]
30. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
31. Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice.
Yang W; Wei J; Sun T; Liu F
Radiat Oncol; 2013 Apr; 8():102. PubMed ID: 23618526
[TBL] [Abstract][Full Text] [Related]
32. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
[TBL] [Abstract][Full Text] [Related]
33. miR-595 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting NF-κB signalling pathway.
Wang H; Jiang F; Liu W; Tian W
Pathol Res Pract; 2020 Apr; 216(4):152899. PubMed ID: 32107085
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
[TBL] [Abstract][Full Text] [Related]
35. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
36. Inhibiting p21-activated kinase (PAK7) enhances radiosensitivity in hepatocellular carcinoma.
Gu YF; Kong LT
Hum Exp Toxicol; 2021 Dec; 40(12):2202-2214. PubMed ID: 34165002
[TBL] [Abstract][Full Text] [Related]
37. miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.
Wang W; Zhang H; Wang L; Zhang S; Tang M
Biochem Biophys Res Commun; 2016 May; 473(4):987-992. PubMed ID: 27049311
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
Wang XP; Yao J; Guan J; Zhou ZQ; Zhang ZY; Yang J
Biomed Pharmacother; 2018 Mar; 99():817-824. PubMed ID: 29710480
[TBL] [Abstract][Full Text] [Related]
39. Effects of hsa_circRBM23 on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 Expression.
Wang B; Chen H; Zhang C; Yang T; Zhao Q; Yan Y; Zhang Y; Xu F
Cancer Biother Radiopharm; 2018 Jun; 33(5):194-202. PubMed ID: 29916745
[TBL] [Abstract][Full Text] [Related]
40. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
